Latest Blogs

Women in Oncology
May 25, 2018
Connect, Collaborate, and Learn at #ASCO18 Women's Networking Center
Dr. Jane Lowe Meisel shares a first look at the program for the Women's Networking Center at the 2018 ASCO Annual Meeting. 
Guest Commentary
May 25, 2018
Expect Innovation, Excellence at ASCO Research Community Forum 2018 Annual Meeting
Dr. Edward S. Kim encourages you to register today and join the Research Community Forum in September for 2 days of learning and collaboration.
Nagi S. El Saghir, MD, FACP, FASCO
May 24, 2018
Pan-Arab Cancer Congress 2018 in Tunisia: Science and Patient Care Never Stop
In the midst of troubles in North Africa and Middle East, we keep up with oncology education and research and keep up hope for the betterment of patient care and advancement of science in Arab countries. 
Clifford A. Hudis, MD, FACP, FASCO
May 24, 2018
Biosimilars: A Conversation With Dr. Gary H. Lyman
While more biosimilars will likely be available in oncology in the next several years, their specific impact on patient care is going to depend on patient and provider acceptance of these agents.
Subscribe to this column

Edward Paul Balaban, DO, FACP, FASCO

Edward P. Balaban, DO, FACP, FASCO, is the Medical Director for the Cancer Care Partnership with Penn State University Cancer Institute and Professor of Medicine Penn State Hershey Cancer Institute. He currently serves as a Practice Guideline Implementation Network (PGIN) representative for Weight-Based Dosing Chemotherapy for Cancer Patients and Gastrointestinal Guideline Advisory Groups. Dr. Balaban is also Past President of the Pennsylvania Society of Oncology and Hematology and the delegate representing ASCO at the AMA-House of Delegates.

Nov 20, 2017
Aloha from the ASCO AMA House of Delegates
The ASCO delegation was very busy at the American Medical Association House of Delegates recent interim meeting.
Jun 29, 2017
AMA House of Delegates: These are Impactful Times
The most recent meeting of the AMA House of Delegates was a particularly important one for oncologists and cancer-related issues.
Nov 28, 2016
Become Engaged, Stay Engaged: More Important Than Ever
We (the ASCO delegation) have just returned from the interim American Medical Association (AMA) House of Delegates meeting in Orlando. ASCO proposed a resolution focused on the restrictive opioid policies being adopted by many states. Many of the state legislations include language restricting...
Jun 22, 2016
So Much Done, So Much More to Do: AMA House of Delegates Report
ASCO composed and successfully brought to the AMA-HOD several resolutions representing some of our most pressing concerns and/or initiatives, including regulations on handling hazardous materials, transparency on clinical pathways, reimbursement models, and Part B drug payments.
Jan 05, 2016
AMA House of Delegates: A Glimpse into the Future
ASCO staff and  member representatives gathered in Atlanta for the AMA House of Delegates' recent meeting, and, as usual, listened, learned, and spoke on a number of topics.
Jun 18, 2015
It’s Good to Grow—with the AMA-HOD
The AMA House of Delegates (AMA-HOD) convened a few days after the ASCO Annual Meeting.  It was, in many ways, a continuation of many of the concerns reviewed at the annual ASCO gathering. The delegation representing ASCO is now composed of ASCO staff, along with Drs. Thomas Marsland, Ray Page,...

Pages